Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlencowe Resources Regulatory News (BRES)

Share Price Information for Blencowe Resources (BRES)

Share Price is delayed by 15 minutes
Get Live Data
8.10    0.06 (0.75%)
Bid:
7.90
Ask:
8.30
Spread: 0.40 (5.063%)
Market Cap: £39.85m
BRES Live PriceLast checked at - London Stock Exchange

Intraday Blencowe Resources Share Chart

Testwork Confirms Highest Purity

15 Jan 2026 07:14

RNS Number : 0355P
Blencowe Resources PLC
15 January 2026
 

Date: 15 January 2026

 

Blencowe Resources Plc

("Blencowe" or the "Company"),

 

European Purification Testwork Confirms Highest Purity Graphite Products

Results Strengthen Strategic Value of Orom-Cross for High-Value Defence and Energy Markets

 

 

Blencowe Resources Plc (LSE: BRES) is pleased to announce further exceptional high-grade purification results from testwork undertaken in association with Alkeemia S.P.A.("Alkeemia"), a specialist graphite processing organisation based in Porto Marghera, Northern Italy. This is the first Orom-Cross purification test work conducted within the EU and it represents a bridge into that significant market moving forward.

 

Highlights

· Purification testing upgraded all Orom-Cross products to 99.99 carbon content. It is extremely rare for purified graphite to achieve these 4-nines.

· Four-nines purity is considered the highest purification grade possible and is required for lucrative defence, nuclear and specialist energy applications.

· Independent European processing confirms non-Chinese purification capability.

· Alkeemia's process offers a cleaner, lower-toxicity and lower-carbon alternative to conventional Chinese technologies.

· Independent testing by a specialist European firm strengthens ongoing offtake discussions and opens additional sales opportunities into European markets.

· Discussions with Alkeemia regarding potential direct offtake and European purification arrangements.

 

Strategic Significance

Initial results show that all Orom-Cross concentrates tested were successfully upgraded using Alkeemia's proprietary process to achieve 99.99% carbon content, exceeding the 99.95% purity typically required for lithium-ion battery applications.

This level of purity enables Blencowe to target higher-value, strategically important end markets including niche defence and nuclear and specialist industrial applications where product quality, traceability and supply security are critical.

Importantly, the Alkeemia process provides a Western, non-Chinese, purification route, utilising a simpler, less toxic, and more cost-effective methodology than conventional acid-based processes widely used in China. This further aligns Orom-Cross with growing European and US policy objectives to establish secure independent, and sustainable critical mineral supply chains.

Orom-Cross has previously achieved 99.99% purity through testwork conducted by American Energy Technology ("AETC"), a US based technical graphite specialist, using their own proprietary thermal process that differs from the chemical-based approach employed by Alkeemia. The AETC relationship has since evolved to introduce Blencowe a range of valuable niche offtake opportunities, including testing with US Dept of Defence and the EU SAFELOOP initiative. 

Blencowe believes that engagement with Alkeemia has the potential to develop in a similar manner providing a gateway to European downstream markets. With AETC and Alkeemia utilising different purification methodologies, the Company is also broadening its downstream optionality across multiple high-purity processing routes.

 

Figure 1: Purification testing on Orom-Cross products.

 

Future Relationship

Blencowe and Alkeemia have identified areas of mutual technical and commercial interest and are continuing discussions regarding potential future collaboration.

The ability to deliver ultra-high-purity graphite products through a European-based purification route adds further upside potential to the DFS economics by expanding access to higher-margin, supply-constrained end markets. Engagement with specialist European processors such as Alkeemia also provides valuable technical validation and supports broader dialogue with a wider range of downstream customers and strategic end users, particularly within Europe.

 

Cameron Pearce, Blencowe's Executive Chairman commented:

"These purification results are a significant milestone for Orom-Cross and once again demonstrate that our graphite can achieve the very highest purity levels required for specialist applications, including defence, nuclear and strategic energy uses where quality and supply security are critical. It also opens the potential for a valuable new partnership to develop.

Achieving 99.99% carbon content through a non-Chinese, European-based purification route materially enhances the strategic value of Orom-Cross. It positions the project not only as a large-scale, low-cost graphite development, but also as a credible contributor to Western critical mineral supply chains.

Importantly, this work adds further upside potential to the economics outlined in our DFS by broadening access to higher-margin, supply-constrained markets. Combined with the scale we continue to demonstrate through drilling, this reinforces Orom-Cross as a long-life, strategically relevant asset as we advance funding and offtake discussions."

 

**ENDS**

 

For further information please contact:

 

Blencowe Resources Plc

www.blencoweresourcesplc.com

 

Sam Quinn (Director)

Tel: +44 (0)1624 681 250

info@blencoweresourcesplc.com

 

Sasha Sethi (Investor Relations)

Tel: +44 (0) 7891 677 441

sasha.sethi@blencoweresourcesplc.com

Tavira Financial (Joint Broker)

 

Jonathan Evans

 

 

Tel: +44 (0)20 3192 1733

jonathan.evans@tavira.group

Oak Securities (Joint Broker)

 

Calvin Man /Mungo Sheehan / Jerry Keen

 

 

Tel: +44 (0)20 3973 3678

Twitter

https://twitter.com/BlencoweRes

LinkedIn

https://www.linkedin.com/company/72382491/admin/

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVONRNNUAARR
Date   Source Headline
19th Nov 20248:00 amRNSShareholder Question & Answers
13th Nov 20247:00 amRNS6,700m Drilling Programme to Commence
12th Nov 20243:11 pmRNSHolding(s) in Company
7th Nov 20247:00 amRNSResults of Retail Offer
6th Nov 20247:01 amRNSBookBuild Retail Offer
6th Nov 20247:00 amRNSCapital Raise of £1.5m
8th Oct 20247:00 amRNSGlobal MSP Accreditation
5th Sep 20247:00 amRNSMoU signed for Graphite Beneficiation in Uganda
2nd Sep 20247:00 amRNS600 tonne Processing Graphite to Battery Ready SPG
22nd Jul 20247:00 amRNSIssue of Equity
15th Jul 20247:00 amRNSDFC Grant Fourth Tranche
5th Jul 20247:00 amRNSConversion of 600t bulk sample to concentrate
25th Jun 20247:17 amRNS600t Bulk Sample Nearing Completion
14th Jun 20247:00 amRNSHalf-year Report
10th Jun 20247:00 amRNSFirst offtake for 15,000 tonnes
3rd Jun 20247:00 amRNSCorporate Presentation Updated
28th May 20249:00 amRNSCEO Video Interview
15th Apr 20247:00 amRNSBulk Sample Update
10th Apr 20247:00 amRNSReceipt of Third Tranche from DFC
26th Feb 20248:52 amRNSResult of AGM
9th Feb 20247:00 amRNSSubscription & Conditional Subscription - Replace
6th Feb 20247:00 amRNSSubscription & Conditional Subscription
31st Jan 20247:00 amRNSAnnual Financial Report
29th Jan 20247:00 amRNSDFC LOI Regarding Project Financing
25th Jan 20247:00 amRNSReceipt of further $1m Tranche from the DFC
2nd Jan 20247:00 amRNSProject Update
11th Dec 20237:00 amRNSDFS Update
30th Oct 20237:00 amRNSSPG Test Work Completed
10th Oct 202312:16 pmRNSReceipt of $1m Grant First Tranche from DFC
22nd Sep 20237:05 amRNSCorporate Presentation
22nd Sep 20237:00 amRNSDFC Grant Completed
4th Sep 20237:00 amRNSBulk Sampling Completed
23rd Aug 20237:16 amRNSHolding(s) in Company
14th Aug 20237:57 amRNSBulk Sampling Update & China Visit
18th Jul 20237:00 amRNSWarrants Update
22nd Jun 20231:49 pmRNSCEO Interview
19th Jun 20237:00 amRNSMetallurgical test work results
2nd Jun 20237:00 amRNSHalf-year Report
24th May 20238:59 amRNSHolding(s) in Company
18th May 20237:46 amRNSPlacing to Raise £635,000
9th May 20237:00 amRNSWebinar Today
2nd May 20237:11 amRNSInvestor Webinar & Updated Presentation
27th Apr 20233:22 pmRNSStrategic Funding Partner for Orom-Cross
18th Apr 20237:00 amRNSWarrant Expiry Extension
2nd Mar 20237:49 amRNSResearch Note
27th Feb 20237:00 amRNSBulk Sampling Complete
15th Feb 202310:17 amRNSResult of AGM
23rd Jan 20237:00 amRNSAppointment of Leading Engineering Firm to DFS
16th Jan 20237:00 amRNSFinal Metallurgical Testing Programs
13th Jan 20237:00 amRNSAnnual Results 30 September 2022 & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.